Angiotensin blockade therapy and survival in pancreatic cancer: a population study

Overview of attention for article published in BMC Cancer, February 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#5 of 8,906)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

So far, Altmetric has seen 79 news stories from 50 outlets.

Popular blood pressure medications may add years to the lives of patients with pancreatic cancer, a notoriously tough-to-treat…

March 7, 2022 -- Popular blood pressure medications may add years to the lives of patients with pancreatic cancer, a…

(HealthDay News) — Use of angiotensin II receptor blockers (ARBs) and angiotensin I converting enzyme (ACE) inhibitors after a…

Mortality risk reduced for patients exposed to ARBs after PC diagnosis and for those exposed to ACE inhibitors in first three…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 75 additional news stories.